Holen Sie sich die Stockscreener-App
7.31
0.69%
0.05
Schlusskurs vom Vortag:
$7.26
Offen:
$7.34
24-Stunden-Volumen:
25,146
Relative Volume:
0.48
Marktkapitalisierung:
$421.75M
Einnahmen:
$181.68M
Nettoeinkommen (Verlust:
$20.37M
KGV:
20.92
EPS:
0.3495
Netto-Cashflow:
$17.31M
1W Leistung:
-1.75%
1M Leistung:
-6.64%
6M Leistung:
+1.25%
1J Leistung:
+1.25%
1-Tages-Spanne:
$7.24
$7.39
1-Wochen-Bereich:
$7.24
$7.52
52-Wochen-Spanne:
$6.50
$9.35
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
7.31 | 421.75M | 181.68M | 20.37M | 17.31M | 0.3495 |
TAK
Takeda Pharmaceutical Co Adr
|
15.63 | 49.39B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.96 | 39.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.48 | 36.66B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.71 | 33.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
536.59 | 22.78B | 3.17B | 1.29B | 1.01B | 27.09 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Eingeleitet | The Benchmark Company | Buy |
| 2024-07-03 | Eingeleitet | Stifel | Buy |
| 2018-02-02 | Eingeleitet | Chardan Capital Markets | Buy |
Kamada Ltd Aktie (KMDA) Neueste Nachrichten
How Kamada Ltd. (KMDA) Affects Rotational Strategy Timing - Stock Traders Daily
Kamada Stockweekly review against biotech peers - AD HOC NEWS
Kamada schedules annual shareholder meeting for August in Rehovot By Investing.com - Investing.com Canada
Kamada schedules annual shareholder meeting for August in Rehovot - Investing.com
Kamada (NASDAQ: KMDA) plans 2026 AGM on directors, option grants and ISO pool - Stock Titan
Kamada Ltd (KMDA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Kamada Ltd (KMDA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Kamada Ltd (KMDA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Kamada Ltd (KMDA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Kamada Ltd (KMDA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Kamada Ltd (KMDA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
KMDA News | KAMADA LTD (NASDAQ:KMDA) - ChartMill
Goalscorer Kamada credits ex-Palace boss Glasner for his Japan turnaround - The Japan Times
Daichi Kamada steals a point - The Financial Express
Crystal Palace at World Cup: Daichi Kamada reacts to ‘lucky’ equaliser vs Netherlands - Read Crystal Palace
How Kamada became Japan’s unlikely hero in World Cup classic vs Netherlands - The Indian Express
Japan vs Netherlands FIFA World Cup Match Result: Kamada's 88th-minute heroics rescue Japan in dramatic d - The Times of India
Daichi Kamada’s Late Header Gives Japan a 2-2 Draw with the Netherlands in World Cup Opener for Both - Kiripost
World Cup 2026: Kamada’s late header snatches draw for Japan against Netherlands - Business News Nigeria
Netherlands vs Japan highlights: Daichi Kamada’s late equalizer rescues Samurai Blue in FIFA World Cup th - The Times of India
Japan vs Netherlands: Kamada's Late Goal Secures 2-2 Draw - The News Mill
Kamada’s Late Header Earns Japan Thrilling 2-2 Draw Against Netherlands - NewsGhana
FIFA World Cup 2026: Late Kamada goal gives Japan point against NetherlandsNED vs JAP player ratings - Sportstar
Kamada Ltd. (KMDA) Holds Steady at $7.44 as Consolidation ContinuesSmart Beta Flow - newsline.com
KMDA Q1 2026 Earnings: EPS Misses Estimates Amid Operational ChallengesRevenue Miss Report - newsline.com
(KMDA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
KMDA Q1 2026 Earnings: EPS Misses Estimates Amid Revenue Disclosure GapRevenue Surprise History - newsline.com
Kamada (KMDA) Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesGuidance Accuracy Score - newsline.com
MRVI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Why Is Kamada Ltd. (KMDA) Stock Down Today? - Meyka
KMDA Q1 2026 Earnings: EPS Misses Estimates as Stock Slips -2.85%Forward Guidance Trends - newsline.com
Kamada: Undervalued, Yet Execution Risks Keep It A Hold (NASDAQ:KMDA) - Seeking Alpha
Kamada gets FDA approval for Rapid Fluorescent Focus Inhibition Test laboratory - TipRanks
Kamada (KMDA) Receives FDA Nod for New Fluorescent Focus Inhibition Test - GuruFocus
Kamada receives FDA approval for rabies antibody testing lab By Investing.com - Investing.com Australia
Kamada receives FDA approval for rabies antibody testing lab - Investing.com
Kamada Receives FDA Approval for In-House Rabies Virus Neutralization Testing Laboratory - geneonline.com
Kamada Wins FDA Nod for New In‑House Rabies Antibody Testing Lab - TipRanks
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory - The Manila Times
Kamada (KMDA) wins FDA approval for in-house RFFIT rabies antibody testing lab - Stock Titan
KMDA Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesMargin Compression Risk - newsline.com
Kamada (KMDA) Slides 0.64% as Price Tests Key Support Zone Near $7.42Sign of Weakness - The Legal Advocate
Kamada Ltd. (KMDA) Holds Steady Near Support as Trading Volume Remains ModerateRTH Profile - newsline.com
Kamada Ltd stock (IL0010952647): shares stabilize after recent results as investors eye valuation me - AD HOC NEWS
Kamada Ltd. (KMDA) Climbs 1.66% as Shares Approach Key Resistance at $8.36Jurik MA - The Legal Advocate
KMDA Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock ReactionOperating Margin Analysis - The Legal Advocate
Kamada Q1 earnings call highlights - MSN
KMDA Insider Transactions: Officers & Directors File Initial Holdings, May 21, 2026 - Meyka
Kamada Ltd Earnings Call Balances Growth And Risks - The Globe and Mail
Benchmark reiterates Kamada stock Buy rating after Q1 miss By Investing.com - Investing.com Australia
Benchmark reiterates Kamada stock Buy rating after Q1 miss - Investing.com
Finanzdaten der Kamada Ltd-Aktie (KMDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
11.23%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):